ABP-话题@MedSci

#ABP#

34篇内容 | 819人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2049838, encodeId=df542049838df, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, objectTitle=CMIT 2021 | 胡新央：IABP术后抗凝，所有患者都必须使用吗？, objectType=article, longId=220907, objectId=5bb622090e74, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bb622090e74, replyNumber=0, likeNumber=44, createdTime=2022-07-01, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bb622090e74, moduleTitle=CMIT 2021 | 胡新央：IABP术后抗凝，所有患者都必须使用吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5bb622090e74)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049839, encodeId=ac102049839f8, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, objectTitle=ABPA有什么特点？, objectType=article, longId=294709, objectId=53ef294e0951, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53ef294e0951, replyNumber=0, likeNumber=22, createdTime=2022-08-29, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53ef294e0951, moduleTitle=ABPA有什么特点？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53ef294e0951)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049836, encodeId=125e204983636, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, objectTitle=Agendia的MammaPrint®检测在NSABP B-42试验中率先展示出预测延长内分泌治疗所带来收益的能力, objectType=article, longId=212571, objectId=42fb2125e188, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42fb2125e188, replyNumber=0, likeNumber=33, createdTime=2022-03-26, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42fb2125e188, moduleTitle=Agendia的MammaPrint®检测在NSABP B-42试验中率先展示出预测延长内分泌治疗所带来收益的能力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42fb2125e188)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049837, encodeId=6f4e204983ec0, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, objectTitle=J HEPATOLOGY：尿液中肝脏脂肪酸结合蛋白(L-FABP)是失代偿期肝硬化患者慢性肝衰竭和死亡率的预后生物标志物, objectType=article, longId=217902, objectId=5acc21e902a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5acc21e902a0, replyNumber=0, likeNumber=48, createdTime=2022-03-15, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5acc21e902a0, moduleTitle=J HEPATOLOGY：尿液中肝脏脂肪酸结合蛋白(L-FABP)是失代偿期肝硬化患者慢性肝衰竭和死亡率的预后生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5acc21e902a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049833, encodeId=9c18204983307, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, objectTitle=Ann Intensive Care：阜外医院超百例ECMO救治心原性休克经验：同时应用IABP可降低院内死亡率 , objectType=article, longId=186797, objectId=8a16186e974c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a16186e974c, replyNumber=0, likeNumber=22, createdTime=2020-08-09, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a16186e974c, moduleTitle=Ann Intensive Care：阜外医院超百例ECMO救治心原性休克经验：同时应用IABP可降低院内死亡率 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a16186e974c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049834, encodeId=dc432049834ac, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, objectTitle=中国NMPA授予Omadacycline优先审查：治疗社区获得性细菌性肺炎（CABP）等, objectType=article, longId=193655, objectId=d3a919365588, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3a919365588, replyNumber=0, likeNumber=39, createdTime=2020-08-04, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3a919365588, moduleTitle=中国NMPA授予Omadacycline优先审查：治疗社区获得性细菌性肺炎（CABP）等, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3a919365588)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049832, encodeId=0cb8204983235, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, objectTitle=Sci Rep：FABP5能够协同脂质信号促进前列腺癌的转移, objectType=article, longId=184942, objectId=7e66184942db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e66184942db, replyNumber=0, likeNumber=42, createdTime=2020-06-05, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e66184942db, moduleTitle=Sci Rep：FABP5能够协同脂质信号促进前列腺癌的转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e66184942db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049835, encodeId=6a25204983532, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, objectTitle=Thyroid：甲状腺功能正常人群A-FABP水平升高与甲状腺激素敏感性降低有关, objectType=article, longId=194613, objectId=ebe1194613cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebe1194613cb, replyNumber=0, likeNumber=34, createdTime=2021-02-25, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebe1194613cb, moduleTitle=Thyroid：甲状腺功能正常人群A-FABP水平升高与甲状腺激素敏感性降低有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebe1194613cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049831, encodeId=b9902049831fe, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, objectTitle=心血管术后心原性休克患者同时启动IABP效果更好, objectType=article, longId=167362, objectId=446016e3627d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=446016e3627d, replyNumber=0, likeNumber=33, createdTime=2019-06-24, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=446016e3627d, moduleTitle=心血管术后心原性休克患者同时启动IABP效果更好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=446016e3627d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049830, encodeId=ecae2049830ff, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, objectTitle=Generex生物制药公司与NSABP基金会签署临床试验协议：开展AE37联合Pembrolizumab治疗三阴性乳腺癌的临床试验, objectType=article, longId=154590, objectId=ddf915459011, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddf915459011, replyNumber=0, likeNumber=31, createdTime=2019-04-26, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddf915459011, moduleTitle=Generex生物制药公司与NSABP基金会签署临床试验协议：开展AE37联合Pembrolizumab治疗三阴性乳腺癌的临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ddf915459011)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049828, encodeId=159020498285d, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, objectTitle=Liver Int：FABP4，通常在肝脏中不表达的FABP，可以由肝细胞和HCC细胞合成和分泌，可能会调节肿瘤进展, objectType=article, longId=140207, objectId=65b614020e9f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65b614020e9f, replyNumber=0, likeNumber=39, createdTime=2018-10-13, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65b614020e9f, moduleTitle=Liver Int：FABP4，通常在肝脏中不表达的FABP，可以由肝细胞和HCC细胞合成和分泌，可能会调节肿瘤进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65b614020e9f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049826, encodeId=1e5d2049826c2, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, objectTitle=NAT Immunol：林欣实验室在《自然 - 免疫学》发文报道 CARD9 基因多样性诱导 ABPA 发病的作用机制, objectType=article, longId=138733, objectId=7c82138e3343, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c82138e3343, replyNumber=0, likeNumber=34, createdTime=2018-12-06, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c82138e3343, moduleTitle=NAT Immunol：林欣实验室在《自然 - 免疫学》发文报道 CARD9 基因多样性诱导 ABPA 发病的作用机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c82138e3343)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049829, encodeId=5161204982984, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, objectTitle=安进公司宣布生物仿制药ABP 710的III期临床研究结果, objectType=article, longId=141928, objectId=2c18141928fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c18141928fb, replyNumber=0, likeNumber=0, createdTime=2019-03-27, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c18141928fb, moduleTitle=安进公司宣布生物仿制药ABP 710的III期临床研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c18141928fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049827, encodeId=19ff204982ee8, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, objectTitle=Lancet oncol：ABP980，曲妥珠单抗的生物类似物，用于HER2阳性的乳腺癌患者的效果和安全性，与曲妥珠单抗的不相上下, objectType=article, longId=140064, objectId=732314006499, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=732314006499, replyNumber=0, likeNumber=37, createdTime=2018-07-21, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=732314006499, moduleTitle=Lancet oncol：ABP980，曲妥珠单抗的生物类似物，用于HER2阳性的乳腺癌患者的效果和安全性，与曲妥珠单抗的不相上下, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=732314006499)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049825, encodeId=b75d20498256b, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, objectTitle=NSABP B-47证实HER2低表达乳腺癌未从曲妥珠单抗辅助治疗获益, objectType=article, longId=128634, objectId=47f31286349d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47f31286349d, replyNumber=0, likeNumber=43, createdTime=2019-01-06, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47f31286349d, moduleTitle=NSABP B-47证实HER2低表达乳腺癌未从曲妥珠单抗辅助治疗获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47f31286349d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049824, encodeId=8def2049824e8, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, objectTitle=Chest：伊曲康唑与泼尼松龙治疗急性期ABPA并发哮喘的疗效比较！, objectType=article, longId=126248, objectId=9c3d126248a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c3d126248a6, replyNumber=0, likeNumber=57, createdTime=2018-07-14, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c3d126248a6, moduleTitle=Chest：伊曲康唑与泼尼松龙治疗急性期ABPA并发哮喘的疗效比较！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c3d126248a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049823, encodeId=fd0e2049823ba, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, objectTitle=Liver Int：在人类和动物肝细胞癌模型中：改变的脂肪酸结合蛋白4（FABP4）的表达和功能, objectType=article, longId=121503, objectId=2dbc121503d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2dbc121503d6, replyNumber=0, likeNumber=36, createdTime=2018-10-05, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2dbc121503d6, moduleTitle=Liver Int：在人类和动物肝细胞癌模型中：改变的脂肪酸结合蛋白4（FABP4）的表达和功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2dbc121503d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049822, encodeId=e00a2049822cf, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, objectTitle=Chest：维生素D缺乏是否影响合并ABPA的哮喘患者的Th2应答？, objectType=article, longId=120568, objectId=64f8120568d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64f8120568d3, replyNumber=0, likeNumber=37, createdTime=2017-12-03, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64f8120568d3, moduleTitle=Chest：维生素D缺乏是否影响合并ABPA的哮喘患者的Th2应答？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64f8120568d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049821, encodeId=66ac2049821ed, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, objectTitle=CHC2017：搭桥术后 IABP 护理专家共识发布, objectType=article, longId=108744, objectId=1f42108e4484, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f42108e4484, replyNumber=0, likeNumber=26, createdTime=2018-01-16, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f42108e4484, moduleTitle=CHC2017：搭桥术后 IABP 护理专家共识发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f42108e4484)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049817, encodeId=24e0204981e34, content=<a href='/topic/show?id=4a5f1e68a9' target=_blank style='color:#2F92EE;'>#ABP#</a>, objectTitle=Chin Circul J：大于80岁高危急性心梗患者介入前预防性IABP有助于预防严重事件, objectType=article, longId=97059, objectId=dab59e0598b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dab59e0598b, replyNumber=0, likeNumber=35, createdTime=2017-05-23, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dab59e0598b, moduleTitle=Chin Circul J：大于80岁高危急性心梗患者介入前预防性IABP有助于预防严重事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dab59e0598b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ABP

2020-05-29

wleon8895 (审核中...)

前往app查看评论内容

#ABP#

CMIT 2021 | 胡新央：IABP术后抗凝，所有患者都必须使用吗？

2022-07-01

wleon8895 (审核中...)

前往app查看评论内容

#ABP#

ABPA有什么特点？

2022-08-29

wleon8895 (审核中...)

前往app查看评论内容

#ABP#

Agendia的MammaPrint®检测在NSABP B-42试验中率先展示出预测延长内分泌治疗所带来收益的能力

2022-03-26

wleon8895 (审核中...)

前往app查看评论内容

#ABP#

J HEPATOLOGY：尿液中肝脏脂肪酸结合蛋白(L-FABP)是失代偿期肝硬化患者慢性肝衰竭和死亡率的预后生物标志物

2022-03-15

wleon8895 (审核中...)

前往app查看评论内容

#ABP#

Ann Intensive Care：阜外医院超百例ECMO救治心原性休克经验：同时应用IABP可降低院内死亡率

2020-08-09

wleon8895 (审核中...)

前往app查看评论内容

#ABP#

中国NMPA授予Omadacycline优先审查：治疗社区获得性细菌性肺炎（CABP）等

2020-08-04

wleon8895 (审核中...)

前往app查看评论内容

#ABP#

Sci Rep：FABP5能够协同脂质信号促进前列腺癌的转移

2020-06-05

wleon8895 (审核中...)

前往app查看评论内容

#ABP#

Thyroid：甲状腺功能正常人群A-FABP水平升高与甲状腺激素敏感性降低有关

2021-02-25

wleon8895 (审核中...)

前往app查看评论内容

#ABP#

心血管术后心原性休克患者同时启动IABP效果更好

2019-06-24

wleon8895 (审核中...)

前往app查看评论内容

#ABP#

Generex生物制药公司与NSABP基金会签署临床试验协议：开展AE37联合Pembrolizumab治疗三阴性乳腺癌的临床试验

2019-04-26

wleon8895 (审核中...)

前往app查看评论内容

#ABP#

Liver Int：FABP4，通常在肝脏中不表达的FABP，可以由肝细胞和HCC细胞合成和分泌，可能会调节肿瘤进展

2018-10-13

一叶知秋 (审核中...)

前往app查看评论内容

#ABP#

NAT Immunol：林欣实验室在《自然 - 免疫学》发文报道 CARD9 基因多样性诱导 ABPA 发病的作用机制

2018-12-06

wleon8895 (审核中...)

前往app查看评论内容

#ABP#

安进公司宣布生物仿制药ABP 710的III期临床研究结果

2019-03-27

wleon8895 (审核中...)

前往app查看评论内容

#ABP#

Lancet oncol：ABP980，曲妥珠单抗的生物类似物，用于HER2阳性的乳腺癌患者的效果和安全性，与曲妥珠单抗的不相上下

2018-07-21

wleon8895 (审核中...)

前往app查看评论内容

#ABP#

NSABP B-47证实HER2低表达乳腺癌未从曲妥珠单抗辅助治疗获益

2019-01-06

wleon8895 (审核中...)

前往app查看评论内容

#ABP#

Chest：伊曲康唑与泼尼松龙治疗急性期ABPA并发哮喘的疗效比较！

2018-07-14

wleon8895 (审核中...)

前往app查看评论内容

#ABP#

Liver Int：在人类和动物肝细胞癌模型中：改变的脂肪酸结合蛋白4（FABP4）的表达和功能

2018-10-05

wleon8895 (审核中...)

前往app查看评论内容

#ABP#

Chest：维生素D缺乏是否影响合并ABPA的哮喘患者的Th2应答？

2017-12-03

wleon8895 (审核中...)

前往app查看评论内容

#ABP#

CHC2017：搭桥术后 IABP 护理专家共识发布

2018-01-16

wleon8895 (审核中...)

前往app查看评论内容

#ABP#

Chin Circul J：大于80岁高危急性心梗患者介入前预防性IABP有助于预防严重事件

2017-05-23

科室
- - 订阅+
  - 更多科室
工具
服务